Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Particulate Matter Testing in Liquids

Posted on By

SOP for Particulate Matter Testing in Liquids

Procedure for Particulate Matter Testing in Liquids

1) Purpose

The purpose of this SOP is to outline the procedure for testing particulate matter in liquid samples used in pharmaceutical manufacturing to ensure product quality and safety.

2) Scope

This SOP applies to all liquid formulations produced within the manufacturing facility that require particulate matter testing.

3) Responsibilities

Quality Control (QC) Department: Responsible for conducting particulate matter testing and ensuring compliance with this SOP.
Production Department: Responsible for providing liquid samples and maintaining process parameters.

4) Procedure

4.1 Equipment Preparation:
    4.1.1 Set up the particulate matter testing equipment (e.g., light obscuration particle counter) according to manufacturer’s instructions.
    4.1.2 Calibrate the equipment using certified standard particles of known sizes.
    4.1.3 Ensure the testing area is clean and free from contaminants.

See also  SOP for Compressed Air Quality Testing

4.2 Particulate Matter Testing Procedure:
    4.2.1 Take a representative sample of the liquid formulation for testing.
    4.2.2 Introduce the sample into the particle counter and initiate the testing process.
    4.2.3 Allow the particle counter to analyze the sample and record the particulate matter count and size distribution.
    4.2.4 Repeat the measurement if necessary to ensure accuracy and consistency of results.

4.3 Calculation and Interpretation:
    4.3.1 Compare the measured particulate matter count and size distribution against acceptance criteria specified in pharmacopeial standards or internal specifications.
    4.3.2 Classify particulate matter as viable or non-viable based on size and origin (e.g., intrinsic vs. extrinsic).

See also  SOP for Grittiness Testing in Topical Preparations

4.4 Acceptance Criteria:
    4.4.1 The particulate matter count does not exceed the specified limits for the product.
    4.4.2 The size distribution of particulate matter meets the defined criteria.

4.5 Documentation:
    4.5.1 Record all particulate matter test results, equipment calibration details, and any corrective actions taken in the Particulate Matter Testing Record.
    4.5.2 Review and approve the documentation by QC Manager.

5) Abbreviations, if any

QC: Quality Control

6) Documents, if any

Particulate Matter Testing Record
Calibration Record for Particle Counter
Sampling Plan Document

7) Reference, if any

USP General Chapter <788> – Particulate Matter in Injections
21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals

See also  SOP for Terminal Sterilization Validation

8) SOP Version

Version 1.0

In-Process Control Tags:Blend uniformity testing SOP, Bulk density testing SOP, Capsule content uniformity SOP, Capsule disintegration testing SOP, Capsule dissolution testing SOP, Capsule weight variation SOP, Clarity and opalescence testing of liquids SOP, Endotoxin testing in injectable products SOP, Flowability testing of powders SOP, Granulation size distribution SOP, Moisture content determination in granules SOP, Osmolality testing SOP, Particulate matter testing in liquids SOP, pH measurement of solutions SOP, Pyrogen testing SOP, Specific gravity testing of liquids SOP, Sterility testing SOP, Tablet disintegration testing SOP, Tablet dissolution testing SOP, Tablet friability testing SOP, Tablet hardness testing SOP, Tablet thickness measurement SOP, Tablet weight variation SOP, Uniformity of dosage units SOP, Viscosity testing of liquids SOP

Post navigation

Previous Post: SOP for Environmental Monitoring: Procedures for Monitoring and Controlling the Manufacturing Environment
Next Post: Ointments: SOP for Change Control Procedures in Ointment Formulation

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version